INVO Fertility Stock Slides After Filing Delay
INVO Fertility shares fell 2.4% to $1.60 on Nasdaq after the company said its first-quarter 10-Q filing is delayed due to unfinished work on its 2025 annual report. Nasdaq previously warned INVO for missing the 10-K deadline, but the company said its listing is not immediately affected. Broader U.S. indexes rose Tuesday. INVO cited a recent auditor change and complex accounting matters for the delay.